Profil
Christophe Durand is currently the Chief Executive Officer at Cenexi SAS and Cenexi 2 SASU.
He is also currently serving as the Chairman at Phinex SAS, Cenexi HSC SAS, and Director at Cenexi - Laboratoires Thissen SA. Previously, he served as the President & Director at Phixen SAS from 2020 to 2023.
Aktive Positionen von Christophe Durand
Unternehmen | Position | Beginn |
---|---|---|
Cenexi - Laboratoires Thissen SA
Cenexi - Laboratoires Thissen SA Pharmaceuticals: MajorHealth Technology Part of Phinex SAS, Cenexi - Laboratoires Thissen SA is a development and subcontracting Belgian company specializing in sterile and organic products. Founded in 2012, the company is based in Braine l'Alleud, Belgium. Cenexi partners with pharmaceutical laboratories and biotechs to develop and manufacture innovative drugs. The company's expert entity, Cenexi Services, provides formulation, analytical and galleic developments, industrial transfer, and regulatory support. The company pursues a dynamic recruitment policy, hiring around 125 positions in France and 50 in Belgium every year. | Direktor/Vorstandsmitglied | 22.07.2021 |
Cenexi Hsc SAS
Cenexi Hsc SAS Pharmaceuticals: MajorHealth Technology Cenexi HSC SAS is a French company founded in 2004 that specializes in the development and manufacturing of sterile and biological products. The company is based in Fontenay-sous-Bois, France. The company's services include formulation, analytical and galenic development, industrial transfer, and regulatory support. | Vorsitzender | 01.07.2020 |
Cenexi SAS
Cenexi SAS Pharmaceuticals: MajorHealth Technology Cenexi SASU specializes in the contract manufacturing of pharmaceuticals for humans and veterinary markets. It also manufactures solid forms (tablets and capsules), syrups, suppositories and parental ampoules for the world market. The company was founded in 2004 and is headquartered in Fontenay-sous-Bois, France. | Vorstandsvorsitzender | - |
Phinex SAS
Phinex SAS Financial ConglomeratesFinance Phinex SAS operates as a holding company. The company is headquartered in Fontenay-sous-Bois, France. | Vorsitzender | 20.08.2020 |
Cenexi 2 SASU
Cenexi 2 SASU Pharmaceuticals: MajorHealth Technology Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Cenexi 2 SASU is a contract manufacturing and development organization of pharmaceutical products. The company is based in Fontenay-sous-Bois, France. The French company was founded in 2016. The CEO is Christophe Durand. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Christophe Durand
Unternehmen | Position | Ende |
---|---|---|
Phixen SAS
Phixen SAS Financial ConglomeratesFinance Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Phixen SAS is an investment holding French company. The company is based in Fontenay-sous-Bois, France. Founded in 2015. Phixen was acquired by Gland Pharma International Pte Ltd (Singapore) on April 27, 2023 for $124.77 million. | Präsident | 19.09.2023 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
Cenexi SAS
Cenexi SAS Pharmaceuticals: MajorHealth Technology Cenexi SASU specializes in the contract manufacturing of pharmaceuticals for humans and veterinary markets. It also manufactures solid forms (tablets and capsules), syrups, suppositories and parental ampoules for the world market. The company was founded in 2004 and is headquartered in Fontenay-sous-Bois, France. | Health Technology |
Phinex SAS
Phinex SAS Financial ConglomeratesFinance Phinex SAS operates as a holding company. The company is headquartered in Fontenay-sous-Bois, France. | Finance |
Phixen SAS
Phixen SAS Financial ConglomeratesFinance Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Phixen SAS is an investment holding French company. The company is based in Fontenay-sous-Bois, France. Founded in 2015. Phixen was acquired by Gland Pharma International Pte Ltd (Singapore) on April 27, 2023 for $124.77 million. | Finance |
Cenexi - Laboratoires Thissen SA
Cenexi - Laboratoires Thissen SA Pharmaceuticals: MajorHealth Technology Part of Phinex SAS, Cenexi - Laboratoires Thissen SA is a development and subcontracting Belgian company specializing in sterile and organic products. Founded in 2012, the company is based in Braine l'Alleud, Belgium. Cenexi partners with pharmaceutical laboratories and biotechs to develop and manufacture innovative drugs. The company's expert entity, Cenexi Services, provides formulation, analytical and galleic developments, industrial transfer, and regulatory support. The company pursues a dynamic recruitment policy, hiring around 125 positions in France and 50 in Belgium every year. | Health Technology |
Cenexi Hsc SAS
Cenexi Hsc SAS Pharmaceuticals: MajorHealth Technology Cenexi HSC SAS is a French company founded in 2004 that specializes in the development and manufacturing of sterile and biological products. The company is based in Fontenay-sous-Bois, France. The company's services include formulation, analytical and galenic development, industrial transfer, and regulatory support. | Health Technology |
Cenexi 2 SASU
Cenexi 2 SASU Pharmaceuticals: MajorHealth Technology Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Cenexi 2 SASU is a contract manufacturing and development organization of pharmaceutical products. The company is based in Fontenay-sous-Bois, France. The French company was founded in 2016. The CEO is Christophe Durand. | Health Technology |